✦ LIBER ✦

The failure of torcetrapib: what have we learned?

✍ Scribed by T R Joy; R A Hegele

Book ID: 109839047
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 64 KB
Volume: 154
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bjp.2008.248

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SARS: What have we learned?

📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 898 KB

XBRL filings: What have we learned?

✍ Thomas R. Weirich; Steven A. Harrast 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract In January 2009, the Securities and Exchange Commission (SEC) mandated the use of eXtensible Business Reporting Language (XBRL) financial statement reports. The current filing process with the SEC will undergo a major change under XBRL, but the new rules are taking effect over a three‐y

Loeffler endocarditis: What have we lear

Loeffler endocarditis: What have we learned?

✍ Juan Benezet-Mazuecos; Adolfo de la Fuente; Pedro Marcos-Alberca; Jeronimo Farre 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

What we have learned from Fukushima

✍ Nagara Tamaki; Fumio Shishido 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 54 KB

What have we learned about sex ?

✍ Seward Hiltner 📂 Article 📅 1953 🏛 Springer 🌐 English ⚖ 115 KB

Inflation Targeting: What Have We Learne

Inflation Targeting: What Have We Learned?

✍ Carl E. Walsh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 636 KB